Clik here to view.
Federal investigators subpoena Biogen over MS drug prices
Biogen (NSDQ:BIIB) said on Thursday that it received a subpoena in December last year from federal investigators about the prices of its top-selling multiple sclerosis drugs, Tecfidera, Avonex, Tysabri...
View ArticleClik here to view.
Health insurance industry committee says yes to UDIs in claims forms
The X12 advisory committee—which helps formulate standards for the insurance industry— has recommende d changes that will allow standard health insurance claims forms to record unique device...
View ArticleClik here to view.
Viveve moves headquarters to Colorado
Viveve (NSDQ:VIVE) said today it is relocating its corporate headquarters to Englewood, Colo. from Sunnyvale, Calif. The company said it signed a lease agreement for a new facility in Englewood, with...
View ArticleClik here to view.
Donald Trump: What medtech’s top executives are saying
For the most part, the medical device industry’s top executives have sounded positive about the new Trump administration and Republican Congress during recent earnings calls with analysts. Some such...
View ArticleClik here to view.
Amgen tops Q4 earnings, touts Repatha cardiovascular outcomes
Shares in Amgen (NSDQ:AMGN) rose today after the pharmaceutical company met expectations on Wall Street with its 4th quarter results and touted data from a trial for its cholesterol drug, Repatha. The...
View ArticleClik here to view.
Venture firm Seroba eyeing candidates for $107m investment fund
Venture capital firm Seroba Life Sciences is reportedly considering several candidates for the $107.7 million (EU €100 million) investment fund it just launched. Seroba’s fund itself is supported by...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for February 3, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
7 medtech stories we missed: Feb. 3, 2017
[Image courtesy of Dino Reichmuth on Unsplash]From disappointing Getinge earnings to a $2.25 billion U.S. Defense Department contract for Cardinal Health to a host of 510(k) clearances, here are seven...
View ArticleClik here to view.
Pulmatrix raises $3m in direct offering
Pulmatrix (NSDQ:PULM) said today that unnamed institutional investors agreed to purchase approximately $3.3 million of shares of common stock in a direct offering. The company said it plans to sell...
View ArticleClik here to view.
Fresenius picks up down-under hospital operator Cura Group
Fresenius Medical Care (NYSE:FMS) said today it picked up a majority stake in Australian day hospital operator Cura Group for an undisclosed amount. Cura owns 19 private day hospitals across Australia...
View ArticleClik here to view.
Continuous glucose monitoring lowers blood sugar, Swedish study says
A continuous glucose monitor by Medtronic. It is recommended that those who have type 1 diabetes should prick their finger as a supplement to the continuous glucose monitor. [Image from Medtronic]A new...
View ArticleClik here to view.
NxThera raises $12.2m
NxThera raised $12.2 million in a new round of financing, according to an SEC filing posted this week. Funds in the round come through the offering of debt, warrants, convertible promissory notes and...
View ArticleClik here to view.
Guided Therapeutics inks exclusive distro deal with Shandong Yaohua
Guided Therapeutics (OTC:GTHP) said last week it inked an exclusive distribution, sales and manufacturing rights deal for its LuViva advanced cervical scan system with Shandong Yaohua Medical...
View ArticleClik here to view.
iCad closes sale of VersaVue, DynaCAD to Philips Invivo
iCad (NSDQ:ICAD) said today it closed its sale of its VersaVue software and DynaCAD breast and prostate imaging devices to Royal Philips‘ (NYSE:PHG) Invivo unit for $3.2 million. Nashua, N.H.-based...
View ArticleClik here to view.
New medical device rules from Indian regulators
By Stewart Eisenhart, Emergo Group India’s Ministry of Health and Family Welfare has released long-awaited new medical device and in vitro diagnostic (IVD) regulations that take effect in January 2018....
View ArticleClik here to view.
FDA accepts Intarcia’s NDA for diabetes drug-device combo
Intarcia Therapeutics said today that the FDA accepted its New Drug Application for the 1st drug to use Intarcia’s Medici drug delivery system to treat Type II diabetes. The Medici drug-device combo...
View ArticleClik here to view.
BioVentrix lands German reimbursement win for Revivent system
BioVentrix said today that its Revivent TC transcatheter ventricular enhancement system won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System. This status is the...
View ArticleClik here to view.
Aura Biosciences wins FDA nod for light-activated ocular melanoma treatment
Aura Biosciences said today that the FDA approved its Investigational New Drug Application for the company’s light-activated viral nanoparticle conjugates for the treatment of ocular melanoma. The...
View ArticleClik here to view.
Medtronic wins VA telehealth supply contract
Medtronic (NYSE:MDT) said today its Medtronic Care Management Services won a contract from the US Department of Veterans Affairs to provide home telehealth technologies. The contract will position...
View ArticleClik here to view.
Halt Medical wins Medicaid coverage for Acessa treatment in 5 states
Halt Medical said today it won coverage for its Acessa System from Medicaid in Texas, Ohio, Michigan, Indiana and Washington D.C. The Acessa system uses radiofrequency ablation guided by ultrasound to...
View Article